Retina features - Ophthalmology Times Europe

ADVERTISEMENT

SEARCH
  • home
  • about us
  • contact us
  • subscribe
  • media kit request
 
Retina clinical

HEATAM Meetings 1,2 and 3

01 January 2010

Professor David Wong reports on the third Heavy Tamponade meeting in Amsterdam and explains the background from the first and second events

Diabetic retinopathy: A growing concern in an ageing population

01 January 2010

Diabetic retinopathy is a rising threat as the diabetic population increases

Using imaging to monitor retinal tissue response

01 January 2010

Retinal tissue response after PASCAL laser photocoagulation

Proper supplement use advised for people with, or at risk of, AMD

01 January 2010

The Ophthalmology Times Group talked to an optometrist practice about their experience with ocular nutraceuticals

DME responds to ranibizumab

01 December 2009

Diabetic macular oedema responds to treatment with ranibizumab according to the results of the RESOLVE study.

Low hormones may havbe a role in AMD pathogenesis

01 November 2009

A new hypothesis about the development of AMD points to a role of age-depleted steroidal hormones. An ophthalmologist discusses the evidence supporting this idea.

Addressing diabetic retinopathy by treating underlying disease

01 November 2009

For now, the most effective way to prevent or manage diabetic retinopathy is taking a proactive approach to controlling blood glucose levels and hypertension in patients.

Tele-ophthalmology model for ROP management

01 October 2009

Dr Anand Vinekar descibes how tele-ophthalmology models for ROP can be used in developing countries, using a successful Indian programme as a case study.

Anti-VEGF monotherapy useful option in patients with RAP

01 October 2009

Anti-VEGF monotherapy appears to be an effective treatment for retinal angiomatous proliferation, according to results of a small, retrospective chart review. Although the results indicate that in most cases repeated injections would be needed to achieve improvement of stable vision, treatment based on ocular coherence tomography-confirmed presence of fluid could achieve outcomes similar to monthly injections.

Click here